San Diego-based ResMed said that a trial court ruling from Germany’s Munich District Court found that Fisher & Paykel’s Simplus full face and Eson 2 nasal mask head gear infringes on a ResMed patent in the country.
ResMed said that in a separate European decision, the Opposition Division of the European Patent Office decided that the patent asserted against Fisher & Paykel was valid. The company said that each decision could still be appealed by Fisher & Paykel.
“We applaud the Munich District Court for reaching this just finding, and are exploring all options in light of the fact that Fisher & Paykel is selling CPAP masks with headgear that infringes a valid ResMed patent in Germany. We will continue to defend our intellectual property here and wherever necessary to ensure that patients worldwide continue to receive the high-quality care they deserve,” said ResMed chief administrative officer and global GC David Pendarvis said in a press release.
Fisher & Paykel has not yet responded to the rulings.
Last month, ResMed said that it filed a patent infringement petition with the US International Trade Commissions against Fisher & Paykel.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.